Last updated on September 2018

Open-Label Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel

Brief description of study

This will be an open-label study designed to assess the safety and plasma PK of topically applied IDP-126 Gel compared to Control Gel.

Detailed Study Description

To evaluate the safety and plasma pharmacokinetics (PK) of clindamycin and adapalene in IDP-126 Gel compared with that from Control Gel in subjects with moderate to severe acne vulgaris (acne) during once daily topical application of IDP-126 Gel for 28 days.

Clinical Study Identifier: NCT03653403

Contact Investigators or Research Sites near you

Start Over

Steve Rodgers, PhD

Valeant Site 01
Austin, TX United States
  Connect »